NAS:PPH

VANECK ETF TR

$ 86.25 0.16 ( +0.19%) 01:00 PM EST
PE Ratio:
28.5
PB Ratio:
4.95
Volume:
26.09K
Dividend Yield %:
1.99
Last Holding update 2025-02-26 24 Stocks (0 new)
Value $596.00 Mil Turnover 0 %
Top Holdings: LLY(13.35%) JNJ(6.98%) ABBV(6.78%) NVO(6.68%) MRK(5.37%)
Portfolio Report
Registrant: VanEck Pharmaceutical ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

VANECK ETF TR Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

VANECK ETF TR Key Statistics

Name Value
Day's Open ($) 86.23
Day's Range ($) 85.2 - 86.325
Day's Volume 26,086
52-Week Range ($) 77.67 - 99.51
Beta 0.5
3-Year Sharpe Ratio 0.11
3-Year Sortino Ratio 0.15
Volatility 13.76
14-Day RSI 49.68
14-Day ATR ($) 2.020649
20-Day SMA ($) 85.1375

Fundamental Data

Name Value
Market Cap (Mil $) 611.352
Shares Outstanding (Mil) 7.09
PE Ratio 28.5
PE Ratio (10y Range) 2.53 - 28.45
PE Ratio (10y Median) 23.2
PB Ratio 4.95
PB Ratio (10y Range) 0.13 - 4.91
PB Ratio (10y Median) 3.09

Dividend Data

Name Value
Dividends per Share (TTM) ($) 1.7
Dividend Yield % 1.99
Dividend Yield % (10y Range) 1.43 - 4.47
Dividend Yield % (10y Median) 1.8
Next Dividend Payment Date
Dividend Frequency Quarterly

PPH VANECK ETF TR Fundamental Charts

Historical TTM Price-to-Earnings for PPH VANECK ETF TR

Historical TTM Price-to-Earnings without NRI for PPH VANECK ETF TR

Historical Price-to-Book Ratio for PPH VANECK ETF TR

Historical Dividend Yields for PPH VANECK ETF TR

VANECK ETF TR Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with NAS:PPH

No Available Data

NAS:PPH is held by these investors

No Available Data
VanEck Pharmaceutical ETF Top Holdings of 2024-12-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
LLY 		Eli Lilly and Co
103,128
79,614.8
-1.30%
13.350
-0.17%
0.010
+11.09%
+13.02%
782,148.6
Drug Manufacturers
JNJ 		Johnson & Johnson
287,705
41,607.9
-1.17%
6.980
-0.08%
0.010
+5.50%
+7.10%
369,717.2
Drug Manufacturers
ABBV 		AbbVie Inc
227,624
40,448.8
+0.07%
6.780
0%
0.010
+9.94%
+6.35%
328,163.2
Drug Manufacturers
NVO 		Novo Nordisk AS
462,985
39,826.0
-8.46%
6.680
-0.71%
0.010
-28.62%
-27.00%
274,333.3
Drug Manufacturers
MRK 		Merck & Co Inc
321,913
32,023.9
-1.38%
5.370
-0.07%
0.010
-14.36%
-17.74%
204,155.1
Drug Manufacturers
NVS 		Novartis AG
312,336
30,393.4
-2.12%
5.100
-0.11%
0.020
+15.75%
+18.91%
219,690.1
Drug Manufacturers
AZN 		AstraZeneca PLC
459,560
30,110.4
+0.60%
5.050
+0.03%
0.010
+1.80%
+7.30%
213,997.9
Drug Manufacturers
PFE 		Pfizer Inc
1,104,911
29,313.3
-1.02%
4.920
-0.05%
0.020
-11.94%
-11.97%
130,301.7
Drug Manufacturers
SNY 		Sanofi SA
580,890
28,016.3
+0.81%
4.700
+0.04%
0.020
+0.24%
+9.07%
128,477.7
Drug Manufacturers
BMY 		Bristol-Myers Squibb Co
492,090
27,832.6
-27.78%
4.670
-1.36%
0.020
-19.67%
-14.32%
96,488.5
Drug Manufacturers

VanEck Pharmaceutical ETF's Historical Top Holdings Breakdowns

VanEck Pharmaceutical ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
BMY 		Bristol-Myers Squibb Co2024-12-31Reduce
-1.36%
●
51.92 ($55.92) 59.94
$47.48
-15.08%
Reduce -27.78%
492,090
-189,303
MCK 		McKesson Corp2024-12-31Reduce
-1.13%
●
482.27 ($561.01) 628.5
$689.18
22.85%
Reduce -25.47%
48,339
-16,523
CTLT 		Catalent Inc2024-12-31Sold Out
-1.07%
●
58.48 ($60.42) 63.48
$63.48
5.06%
Sold Out
0
-127,789
TEVA 		Teva Pharmaceutical Industries Ltd2024-12-31Reduce
-0.76%
●
16.43 ($18.2) 22.77
$14.80
-18.67%
Reduce -20.76%
1,152,487
-301,959
NVO 		Novo Nordisk AS2024-12-31Reduce
-0.71%
●
85 ($107.98) 120.04
$61.85
-42.72%
Reduce -8.46%
462,985
-42,803
COR 		Cencora Inc2024-12-31Reduce
-0.62%
●
219.5 ($235.35) 251.55
$282.88
20.19%
Reduce -14.23%
120,216
-19,945
HLN 		Haleon PLC2024-12-31Reduce
-0.47%
●
9.23 ($9.77) 10.54
$10.21
4.45%
Reduce -10.11%
2,853,317
-321,073
ZTS 		Zoetis Inc2024-12-31Reduce
-0.46%
●
162.24 ($178.6) 194.44
$152.30
-14.73%
Reduce -9.71%
157,346
-16,920
VTRS 		Viatris Inc2024-12-31Reduce
-0.38%
●
11.32 ($12.3) 13.37
$8.05
-34.51%
Reduce -20.76%
910,598
-238,596
TAK 		Takeda Pharmaceutical Co Ltd2024-12-31Reduce
-0.35%
●
13.01 ($13.73) 14.43
$15.02
9.36%
Reduce -7.98%
2,055,818
-178,250

VanEck Pharmaceutical ETF Total Holding History ($B)

To

VanEck Pharmaceutical ETF's Asset Allocation

To

VanEck Pharmaceutical ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

VanEck Pharmaceutical ETF's Hypothetical Growth since 2024-12-31

VanEck Pharmaceutical ETF's Yearly Returns

Year Portfolio % % Excess Gain %

VanEck Pharmaceutical ETF's Holdings Heat Map

Size field:

VanEck Pharmaceutical ETF's Holdings Bubble Chart

VanEck Pharmaceutical ETF News

  • 1

Discussions on VANECK ETF TR

User's Avatar
How would you rate this stock? PPH
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.